aTYR PHARMA INC Earnings Per Share (Diluted)
aTYR PHARMA INC (ATYR) reported Earnings Per Share (Diluted) of -$0.11 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-07
- aTYR PHARMA INC earnings per share, diluted for the quarter ending 2026-06-30 was -$0.11.
- aTYR PHARMA INC earnings per share, diluted for the quarter ending 2026-03-31 was -$0.11.
- aTYR PHARMA INC earnings per share, diluted for the quarter ending 2025-12-31 was -$0.14.
- aTYR PHARMA INC earnings per share, diluted for the quarter ending 2025-09-30 was -$0.26.
- aTYR PHARMA INC earnings per share, diluted for fiscal 2025 was -$0.80.
- aTYR PHARMA INC earnings per share, diluted for fiscal 2024 was -$0.86.
- aTYR PHARMA INC earnings per share, diluted for fiscal 2023 was -$0.94.
- aTYR PHARMA INC earnings per share, diluted for fiscal 2022 was -$1.60.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.11 10-Q · filed 2026-08-07 | -$0.22 10-Q · filed 2026-08-07 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2026-03-31 | -$0.11 10-Q · filed 2026-05-15 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.80 10-K · filed 2026-03-05 |
| 2025-09-30 | -$0.26 10-Q · filed 2025-11-06 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.66 10-Q · filed 2025-11-06 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-06-30 | -$0.22 10-Q · filed 2026-08-07 | -$0.39 10-Q · filed 2026-08-07 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-08-07 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-08-07 |
| 2025-03-31 | -$0.17 10-Q · filed 2026-05-15 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.58 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.80 derived: net income ÷ weighted average shares · filed 2026-05-15 |
| 2024-12-31 | -$0.18 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.86 10-K · filed 2026-03-05 |
| 2024-09-30 | -$0.23 10-Q · filed 2025-11-06 | -$0.45 derived: net income ÷ weighted average shares · filed 2025-11-06 | -$0.69 10-Q · filed 2025-11-06 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-03-05 |
| 2024-06-30 | -$0.23 10-Q · filed 2025-08-07 | -$0.46 10-Q · filed 2025-08-07 | -$0.71 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-03-05 |
| 2024-03-31 | -$0.23 10-Q · filed 2025-05-07 | -$0.48 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.68 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.90 derived: net income ÷ weighted average shares · filed 2026-03-05 |
| 2023-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.45 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.67 derived: net income ÷ weighted average shares · filed 2026-03-05 | -$0.94 10-K · filed 2026-03-05 |
| 2023-09-30 | -$0.20 10-Q · filed 2024-11-07 | -$0.42 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.69 10-Q · filed 2024-11-07 | -$0.94 derived: net income ÷ weighted average shares · filed 2025-03-13 |
| 2023-06-30 | -$0.22 10-Q · filed 2024-08-13 | -$0.50 10-Q · filed 2024-08-13 | -$0.76 derived: net income ÷ weighted average shares · filed 2025-03-13 | -$1.16 derived: net income ÷ weighted average shares · filed 2025-03-13 |
| 2023-03-31 | -$0.29 10-Q · filed 2024-05-02 | -$0.55 derived: net income ÷ weighted average shares · filed 2025-03-13 | -$0.98 derived: net income ÷ weighted average shares · filed 2025-03-13 | -$1.41 derived: net income ÷ weighted average shares · filed 2025-03-13 |
| 2022-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2025-03-13 | -$0.72 derived: net income ÷ weighted average shares · filed 2025-03-13 | -$1.16 derived: net income ÷ weighted average shares · filed 2025-03-13 | -$1.60 10-K · filed 2025-03-13 |
| 2022-09-30 | -$0.46 10-Q · filed 2023-11-09 | -$0.90 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.34 10-Q · filed 2023-11-09 | -$1.65 derived: net income ÷ weighted average shares · filed 2024-03-14 |
| 2022-06-30 | -$0.44 10-Q · filed 2023-08-09 | -$0.88 10-Q · filed 2023-08-09 | -$1.19 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$1.60 derived: net income ÷ weighted average shares · filed 2024-03-14 |
| 2022-03-31 | -$0.44 10-Q · filed 2023-05-09 | -$0.74 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$1.15 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$1.72 derived: net income ÷ weighted average shares · filed 2024-03-14 |
| 2021-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$0.70 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$1.28 derived: net income ÷ weighted average shares · filed 2024-03-14 | -$1.77 10-K · filed 2024-03-14 |
| 2021-09-30 | -$0.42 10-Q · filed 2022-11-14 | -$1.05 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.56 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$0.64 10-Q · filed 2022-08-15 | -$1.16 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | -$0.51 10-Q · filed 2021-05-14 | |||
| 2020-12-31 | -$1.77 10-K · filed 2023-03-14 | |||
| 2020-03-31 | $0.25 10-Q · filed 2021-05-14 | |||
| 2019-03-31 | -$2.54 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |